- Home
- LXRX vs GPRK Comparison
LXRX vs GPRK Comparison
Compare LXRX & GPRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LXRX | GPRK |
|---|---|---|
| Founded | 1995 | 2002 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 447.0M | 397.8M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | LXRX | GPRK |
|---|---|---|
| Price | $1.14 | $7.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $3.23 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 1.7M | 607.5K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 1.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.65 |
| Revenue | $70,864,000.00 | ★ $525,938,000.00 |
| Revenue This Year | $56.61 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.34 |
| Revenue Growth | ★ 1255.21 | N/A |
| 52 Week Low | $0.28 | $5.66 |
| 52 Week High | $1.66 | $11.67 |
Technical Indicators
Market Signals| Indicator | LXRX | GPRK |
|---|---|---|
| Relative Strength Index (RSI) | 35.78 | 49.85 |
| Support Level | $1.12 | $7.23 |
| Resistance Level | $1.24 | $7.28 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 8.17 | 98.96 |
Price Performance
Historical ComparisonAbout LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.